Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Image-Guided Gynecologic Brachytherapy 12/15/2016 INTERVENTIONAL not-comparable 3,586.75 0 PPROM Registry (Preterm Premature Rupture of Membranes) 12/20/2016 OBSERVATIONAL not-comparable 3,581.75 0 Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy 12/21/2016 INTERVENTIONAL not-comparable 3,580.75 0 A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma 01/02/2017 INTERVENTIONAL not-comparable 3,568.75 0 Prognostic and Predictive Biomarkers in Ovarian Cancers 01/04/2017 INTERVENTIONAL not-comparable 3,566.75 0 Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial 01/05/2017 INTERVENTIONAL not-comparable 3,565.75 0 Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer 01/06/2017 INTERVENTIONAL not-comparable 3,564.75 0 Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery 01/06/2017 INTERVENTIONAL not-comparable 3,564.75 0 Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer 01/10/2017 INTERVENTIONAL not-comparable 3,560.75 0 Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 01/11/2017 INTERVENTIONAL not-comparable 3,559.75 0 Heart Attack Research Program: Platelet Sub-Study (HARP) 01/16/2017 OBSERVATIONAL not-comparable 3,554.75 0 Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer 01/19/2017 INTERVENTIONAL not-comparable 3,551.75 0 Texting for Diabetes 01/20/2017 INTERVENTIONAL not-comparable 3,550.75 0 Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer 01/24/2017 INTERVENTIONAL not-comparable 3,546.75 0 Hysterectomy and OPPortunistic SAlpingectomy 02/08/2017 INTERVENTIONAL not-comparable 3,531.75 0 Electrophysiology of Fetal Arrhythmia 02/08/2017 OBSERVATIONAL not-comparable 3,531.75 0 Materiovigilance After Urinary Incontinence or Prolapse Surgery 02/14/2017 OBSERVATIONAL not-comparable 3,525.75 0 Comparison of the Efficacy of Sacrocolpopexy, the Amreich-Richter Procedure and Transvaginal Mesh 02/15/2017 INTERVENTIONAL not-comparable 3,524.75 0 Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome 02/23/2017 INTERVENTIONAL not-comparable 3,516.75 0 Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. 02/23/2017 INTERVENTIONAL not-comparable 3,516.75 0 Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples 02/24/2017 OBSERVATIONAL not-comparable 3,515.75 0 Hyperandrogenemia and Altered Day-night LH Pulse Patterns 03/03/2017 INTERVENTIONAL not-comparable 3,508.75 0 PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions 03/03/2017 INTERVENTIONAL not-comparable 3,508.75 0 Vitamin B12 Supplementation During Pregnancy on Cognitive Development 03/07/2017 INTERVENTIONAL not-comparable 3,504.75 0 Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience 03/10/2017 OBSERVATIONAL not-comparable 3,501.75 0 Strategies for Pregnancy Achievement 03/21/2017 INTERVENTIONAL not-comparable 3,490.75 0 POWERMOM, A Healthy Pregnancy Research Community 03/21/2017 OBSERVATIONAL not-comparable 3,490.75 0 Fetoscopic Repair of Isolated Fetal Spina Bifida 03/27/2017 INTERVENTIONAL not-comparable 3,484.75 0 Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response 03/30/2017 INTERVENTIONAL not-comparable 3,481.75 0 Study of Food Aversion in Patients With Anorexia Nervosa 04/04/2017 INTERVENTIONAL not-comparable 3,476.75 0 Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease 04/05/2017 INTERVENTIONAL not-comparable 3,475.75 0 Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence 04/07/2017 INTERVENTIONAL not-comparable 3,473.75 0 Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction 04/10/2017 INTERVENTIONAL not-comparable 3,470.75 0 Can Conventional ECG Technology Capture Fetal Cardiac Activity? 04/12/2017 INTERVENTIONAL not-comparable 3,468.75 0 The 3D Cohort Study (Design, Develop, Discover) 04/13/2017 OBSERVATIONAL not-comparable 3,467.75 0 P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 04/13/2017 INTERVENTIONAL not-comparable 3,467.75 0 Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep 04/14/2017 INTERVENTIONAL not-comparable 3,466.75 0 VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer 04/19/2017 INTERVENTIONAL not-comparable 3,461.75 0 Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years 04/20/2017 INTERVENTIONAL not-comparable 3,460.75 0 Vagal Stimulation in POTS 04/21/2017 INTERVENTIONAL not-comparable 3,459.75 0 Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer 04/24/2017 INTERVENTIONAL not-comparable 3,456.75 0 Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence 04/25/2017 INTERVENTIONAL not-comparable 3,455.75 0 Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI 05/02/2017 OBSERVATIONAL not-comparable 3,448.75 0 Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) 05/03/2017 INTERVENTIONAL not-comparable 3,447.75 0 Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer 05/05/2017 INTERVENTIONAL not-comparable 3,445.75 0 PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women 05/09/2017 OBSERVATIONAL not-comparable 3,441.75 0 Early Detection of Breast Cancer in Women With Suspicious Mammograms 05/10/2017 OBSERVATIONAL not-comparable 3,440.75 0 Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial 05/12/2017 INTERVENTIONAL not-comparable 3,438.75 0 IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy 05/12/2017 INTERVENTIONAL not-comparable 3,438.75 0 Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women 05/23/2017 INTERVENTIONAL not-comparable 3,427.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology